Who
Christopher Christie
Director
Company insider
Files Form 4 as: Director, Pacira BioSciences.
In numbers
- Trades disclosed
- 17
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 18 Sep 2019
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | PCRX Pacira BioSciencesPharmaceuticals | SEC FORM 4 Code A | —6,405 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | PCRX Pacira BioSciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,891 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | PCRX Pacira BioSciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,891 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | PCRX Pacira BioSciencesPharmaceuticals | SEC FORM 4 Code A | —6,405 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | PCRX Pacira BioSciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —11,279 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | PCRX Pacira BioSciencesPharmaceuticals | SEC FORM 4 Code A | —6,163 at $0.00 | filing |
| 12 Jun 2024filed 13 Jun 2024 | PCRX Pacira BioSciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —12,179 at $0.00 | filing |
| 12 Jun 2024filed 13 Jun 2024 | PCRX Pacira BioSciencesPharmaceuticals | SEC FORM 4 Code A | —5,230 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | PCRX Pacira BioSciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —12,925 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | PCRX Pacira BioSciencesPharmaceuticals | SEC FORM 4 Code A | —1,775 at $0.00 | filing |
| 8 Jun 2022filed 8 Jun 2022 | PCRX Pacira BioSciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —8,225 at $0.00 | filing |
| 8 Jun 2022filed 8 Jun 2022 | PCRX Pacira BioSciencesPharmaceuticals | SEC FORM 4 Code A | —1,160 at $0.00 | filing |
| 9 Jun 2021filed 11 Jun 2021 | PCRX Pacira BioSciencesPharmaceuticals | SEC FORM 4 Code A | —1,066 at $0.00 | filing |
| 9 Jun 2021filed 11 Jun 2021 | PCRX Pacira BioSciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —7,626 at $0.00 | filing |
| 9 Jun 2020filed 11 Jun 2020 | PCRX Pacira BioSciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —8,027 at $0.00 | filing |
| 9 Jun 2020filed 11 Jun 2020 | PCRX Pacira BioSciencesPharmaceuticals | SEC FORM 4 Code A | —1,260 at $0.00 | filing |
| 18 Sep 2019filed 20 Sep 2019 | PCRX Pacira BioSciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —19,919 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.